Esteves Sérgio Carlos Barros, Nadalin Wladimir, Piske Ronie Leo, Benabou Salomon, Souza Evandro de, Oliveira Antonio Carlos Zuliani de
Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP.
Rev Assoc Med Bras (1992). 2008 Mar-Apr;54(2):167-72. doi: 10.1590/s0104-42302008000200023.
To evaluate results achieved with radiosurgery and complications of the procedure when treating arteriovenous malformations with linear accelerator.
This retrospective study was conducted between October 1993 and December 1996. Sixty-one patients with arteriovenous malformations were treated with radiosurgery utilizing a 6MV energy linear accelerator. Ages of the 32 female and 29 male patients ranged from 6 to 54 years (mean: 28.3 years). The most frequent initial symptom was cephalea (45.9%), followed by neurological deficit (36.1%). Cerebral hemorrhage diagnosed by image was observed in 35 patients (57.3%). Most arteriovenous malformations (67.2%) were graded Spetzler III and IV. Venous stenosis (21.3%) and aneurysm (13.1%) were the most frequent angioarchitecture changes. The dose administered varied from 12 to 27.5Gy in the periphery of the lesion.
Out of twenty-eight patients that underwent conclusive angiography control, complete obliteration was achieved in 18 (72%) and treatment failed in 7 (absence of occlusion with more than 3 years of follow-up). Four were submitted to a second radiosurgery, and one of these has shown obliteration after 18 months of follow-up.
Several factors were analyzed regarding the occlusion rate (gender, age, volume, localization, Spetzler, flow, embolization, total of isocenters, prescribed dose and chosen isodose) and complications (total of isocenters, localization, volume, maximum dose, prescribed dose and chosen isodose). Analyzed variables showed no statistical significance for obliteration of the vessel, as well as for treatment complications. The largest diameter of the arteriovenous malformation, its volume and the dose administered did not influence time of obliteration.
Radiosurgery is effective in the treatment of arteriovenous malformations and can be an alternative for patients with clinical contraindication or with lesions in eloquent areas. In the studied variables no statistically significant correlation was observed between occlusion and treatment complications.
评估使用直线加速器进行放射外科治疗动静脉畸形的效果及该治疗方法的并发症。
本回顾性研究于1993年10月至1996年12月期间进行。61例动静脉畸形患者接受了使用6MV能量直线加速器的放射外科治疗。32例女性和29例男性患者的年龄在6岁至54岁之间(平均28.3岁)。最常见的初始症状是头痛(45.9%),其次是神经功能缺损(36.1%)。经影像学诊断为脑出血的患者有35例(57.3%)。大多数动静脉畸形(67.2%)为Spetzler III级和IV级。静脉狭窄(21.3%)和动脉瘤(13.1%)是最常见的血管结构改变。病变周边给予的剂量在12至27.5Gy之间。
在接受最终血管造影复查的28例患者中,18例(72%)实现了完全闭塞,7例治疗失败(随访超过3年仍未闭塞)。4例患者接受了第二次放射外科治疗,其中1例在随访18个月后显示闭塞。
分析了几个与闭塞率(性别、年龄、体积、位置、Spetzler分级、血流、栓塞、等中心总数、处方剂量和所选等剂量线)和并发症(等中心总数、位置、体积、最大剂量、处方剂量和所选等剂量线)相关的因素。分析的变量对于血管闭塞以及治疗并发症均无统计学意义。动静脉畸形的最大直径、其体积和给予的剂量均不影响闭塞时间。
放射外科治疗动静脉畸形有效,对于有临床禁忌证或病变位于功能区的患者可作为一种选择。在所研究的变量中,未观察到闭塞与治疗并发症之间存在统计学显著相关性。